{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:02:18Z","timestamp":1777399338479,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.cca.2022.04.005","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T09:01:55Z","timestamp":1649408515000},"page":"183-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Biological variation in clozapine and metabolite reporting during therapeutic drug monitoring"],"prefix":"10.1016","volume":"531","author":[{"given":"Pasindu","family":"Wickramarachchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis J.","family":"Orton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2022.04.005_b0005","article-title":"American Society of Clinical Psychopharmacology Corner Treatment-Resistant Schizophrenia: A Brief Overview of Treatment Options","volume":"80","author":"Citrome","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.cca.2022.04.005_b0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40263-017-0411-6","article-title":"Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?","volume":"31","author":"Taylor","year":"2017","journal-title":"CNS Drugs."},{"key":"10.1016\/j.cca.2022.04.005_b0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5498\/wjp.v11.i8.429","article-title":"Clozapine resistant schizophrenia: Newer avenues of management","volume":"11","author":"Chakrabarti","year":"2021","journal-title":"World J. Psychiatry."},{"key":"10.1016\/j.cca.2022.04.005_b0020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/00912700122010717","article-title":"Contributions of five human cytochrome P450 isoforms to the N-demethylation of clozapine in vitro at low and high concentrations","volume":"41","author":"Olesen","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cca.2022.04.005_b0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.jcp.0000106221.36344.4d","article-title":"Influence of Dose, Cigarette Smoking, Age, Sex, and Metabolic Activity on Plasma Clozapine Concentrations: A Predictive Model and Nomograms to Aid Clozapine Dose Adjustment and to Assess Compliance in Individual Patients","volume":"24","author":"Rostami-Hodjegan","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cca.2022.04.005_b0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2125.2007.02852.x","article-title":"Yi-lang Tang, Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia","volume":"64","author":"Tang","year":"2007","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.cca.2022.04.005_b0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/17512433.2019.1617695","article-title":"A comprehensive review of the clinical utility of and a combined analysis of the clozapine\/norclozapine ratio in therapeutic drug monitoring for adult patients","volume":"12","author":"Schoretsanitis","year":"2019","journal-title":"Expert Review of Clinical Pharmacology."},{"key":"10.1016\/j.cca.2022.04.005_b0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.9758\/cpn.2016.14.4.323","article-title":"Clozapine monitoring in clinical practice: Beyond the mandatory requirement","volume":"14","author":"Kar","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.cca.2022.04.005_b0045","first-page":"682","article-title":"Clozapine-induced acute hypertriglyceridemia, Indian Journal of","volume":"39","author":"Kumar","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.cca.2022.04.005_b0050","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2125.1998.00822.x","article-title":"Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance","author":"Schaber","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cca.2022.04.005_b0055","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"The Lancet."},{"key":"10.1016\/j.cca.2022.04.005_b0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.euroneuro.2015.11.006","article-title":"An observational study of clozapine induced sedation and its pharmacological management","volume":"26","author":"Perdigu\u00e9s","year":"2016","journal-title":"European Neuropsychopharmacology."},{"key":"10.1016\/j.cca.2022.04.005_b0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/14740338.2020.1698545","article-title":"The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy","volume":"19","author":"Costa-Dookhan","year":"2020","journal-title":"Expert Opinion on Drug Safety."},{"key":"10.1016\/j.cca.2022.04.005_b0070","unstructured":"RCPAQAP, Chemical Pathology Analytical Performance Specifications. https:\/\/rcpaqap.com.au\/resources\/chemical-pathology-analytical-performance-specifications\/ (accessed February 13, 2022)."},{"key":"10.1016\/j.cca.2022.04.005_b0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pathol.2018.12.418","article-title":"Indirect derivation of biological variation data and analytical performance specifications for therapeutic drug monitoring activities","volume":"51","author":"Chai","year":"2019","journal-title":"Pathology."},{"key":"10.1016\/j.cca.2022.04.005_b0080","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1309\/AJCPB7Q3AHYLJTPK","article-title":"Indirect estimation of pediatric between-individual biological variation data for 22 common serum biochemistries","volume":"143","author":"Loh","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cca.2022.04.005_b0085","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1309\/AJCPHZLQAEYH94HI","article-title":"Derivation of pediatric within-individual biological variation by indirect sampling method an LMS approach","volume":"142","author":"Loh","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cca.2022.04.005_b0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/acps.12673","article-title":"The significance of sampling time in therapeutic drug monitoring of clozapine","volume":"135","author":"Jakobsen","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.cca.2022.04.005_b0095","unstructured":"CLSI document C62-A: Liquid Chromatography-Mass Spectrometry Methods, 1st Edition; Approved Guideline. Wayne, PA. 2014."},{"key":"10.1016\/j.cca.2022.04.005_b0100","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1373\/clinchem.2015.252296","article-title":"Biological variation: The effect of different distributions on estimated within-person variation and reference change values","volume":"62","author":"R\u00f8raas","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2022.04.005_b0105","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cca.2017.02.021","article-title":"Biological variation: Evaluation of methods for constructing confidence intervals for estimates of within-person biological variation for different distributions of the within-person effect","volume":"468","author":"R\u00f8raas","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2022.04.005_b0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10408368909106595","article-title":"Generation and application of data on biological variation in clinical chemistry","volume":"27","author":"Fraser","year":"1989","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.cca.2022.04.005_b0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/JCP.0000000000001050","article-title":"Gemfibrozil May Decrease Norclozapine Elimination","volume":"39","author":"Barclay","year":"2019","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122001255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122001255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:05:03Z","timestamp":1757862303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122001255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":23,"alternative-id":["S0009898122001255"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.04.005","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological variation in clozapine and metabolite reporting during therapeutic drug monitoring","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}